aTyr Pharma reported $16.46M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Ardelyx USD 127.8M 4.42M Sep/2026
aTyr Pharma USD 16.46M 5.07M Sep/2026
Biogen USD 3.9B 18.7M Sep/2026
Bristol-Myers Squibb USD 18.75B 94M Sep/2026
Cipla INR 69.77B 366.6M Sep/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.63M 596K Jun/2026
CSL USD 4.61B 207M Dec/2025
Curis USD 14.97M 898K Mar/2026
GlaxoSmithKline GBP 20.72B 814M Sep/2026
Grifols EUR 2.37B 156.97M Dec/2025
Lakefront Biotherapeutics EUR 48.33M 21.99M Sep/2026
Novartis USD 32.52B 777M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
United Therapeutics USD 624.3M 16.5M Sep/2026